nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—UGT1A3—digestive system—acquired immunodeficiency syndrome	0.00857	0.0563	CbGeAlD
Cyproheptadine—SLC6A2—nerve—acquired immunodeficiency syndrome	0.00829	0.0545	CbGeAlD
Cyproheptadine—DRD2—nerve—acquired immunodeficiency syndrome	0.00755	0.0497	CbGeAlD
Cyproheptadine—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00632	0.0416	CbGeAlD
Cyproheptadine—HTR2A—nerve—acquired immunodeficiency syndrome	0.00498	0.0327	CbGeAlD
Cyproheptadine—HTR2A—endothelium—acquired immunodeficiency syndrome	0.00424	0.0279	CbGeAlD
Cyproheptadine—HTR6—nervous system—acquired immunodeficiency syndrome	0.00387	0.0254	CbGeAlD
Cyproheptadine—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.00377	0.0248	CbGeAlD
Cyproheptadine—HTR6—central nervous system—acquired immunodeficiency syndrome	0.00372	0.0245	CbGeAlD
Cyproheptadine—HTR2B—skin of body—acquired immunodeficiency syndrome	0.00339	0.0223	CbGeAlD
Cyproheptadine—DRD2—retina—acquired immunodeficiency syndrome	0.00313	0.0206	CbGeAlD
Cyproheptadine—HTR6—brain—acquired immunodeficiency syndrome	0.00295	0.0194	CbGeAlD
Cyproheptadine—HTR2B—digestive system—acquired immunodeficiency syndrome	0.00271	0.0178	CbGeAlD
Cyproheptadine—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.00265	0.0174	CbGeAlD
Cyproheptadine—HTR2B—blood—acquired immunodeficiency syndrome	0.00258	0.017	CbGeAlD
Cyproheptadine—CHRM3—digestive system—acquired immunodeficiency syndrome	0.00244	0.016	CbGeAlD
Cyproheptadine—HTR2B—vagina—acquired immunodeficiency syndrome	0.0024	0.0157	CbGeAlD
Cyproheptadine—CHRM2—nervous system—acquired immunodeficiency syndrome	0.00232	0.0152	CbGeAlD
Cyproheptadine—CHRM1—lung—acquired immunodeficiency syndrome	0.00228	0.015	CbGeAlD
Cyproheptadine—HTR2B—lung—acquired immunodeficiency syndrome	0.00227	0.0149	CbGeAlD
Cyproheptadine—HTR2C—nervous system—acquired immunodeficiency syndrome	0.00223	0.0147	CbGeAlD
Cyproheptadine—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.00223	0.0147	CbGeAlD
Cyproheptadine—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.00223	0.0147	CbGeAlD
Cyproheptadine—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.00215	0.0141	CbGeAlD
Cyproheptadine—CHRM1—nervous system—acquired immunodeficiency syndrome	0.00211	0.0139	CbGeAlD
Cyproheptadine—HTR2B—nervous system—acquired immunodeficiency syndrome	0.0021	0.0138	CbGeAlD
Cyproheptadine—HTR2A—retina—acquired immunodeficiency syndrome	0.00206	0.0136	CbGeAlD
Cyproheptadine—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.00203	0.0133	CbGeAlD
Cyproheptadine—HTR2B—central nervous system—acquired immunodeficiency syndrome	0.00202	0.0133	CbGeAlD
Cyproheptadine—SLC6A2—lung—acquired immunodeficiency syndrome	0.00201	0.0132	CbGeAlD
Cyproheptadine—CHRM3—nervous system—acquired immunodeficiency syndrome	0.00189	0.0124	CbGeAlD
Cyproheptadine—HTR1A—nervous system—acquired immunodeficiency syndrome	0.00188	0.0124	CbGeAlD
Cyproheptadine—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.00186	0.0123	CbGeAlD
Cyproheptadine—DRD2—lung—acquired immunodeficiency syndrome	0.00183	0.0121	CbGeAlD
Cyproheptadine—CHRM3—central nervous system—acquired immunodeficiency syndrome	0.00182	0.0119	CbGeAlD
Cyproheptadine—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.00181	0.0119	CbGeAlD
Cyproheptadine—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.00179	0.0118	CbGeAlD
Cyproheptadine—CHRM2—brain—acquired immunodeficiency syndrome	0.00177	0.0116	CbGeAlD
Cyproheptadine—HRH1—digestive system—acquired immunodeficiency syndrome	0.00173	0.0114	CbGeAlD
Cyproheptadine—HTR2C—brain—acquired immunodeficiency syndrome	0.00171	0.0112	CbGeAlD
Cyproheptadine—DRD2—nervous system—acquired immunodeficiency syndrome	0.0017	0.0112	CbGeAlD
Cyproheptadine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.00164	0.0108	CbGeAlD
Cyproheptadine—CHRM1—brain—acquired immunodeficiency syndrome	0.00161	0.0106	CbGeAlD
Cyproheptadine—HTR2B—brain—acquired immunodeficiency syndrome	0.0016	0.0105	CbGeAlD
Cyproheptadine—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.00157	0.00218	CcSEcCtD
Cyproheptadine—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.00156	0.00218	CcSEcCtD
Cyproheptadine—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.00156	0.00218	CcSEcCtD
Cyproheptadine—HTR2B—lymph node—acquired immunodeficiency syndrome	0.00155	0.0102	CbGeAlD
Cyproheptadine—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.00154	0.00215	CcSEcCtD
Cyproheptadine—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.00154	0.00215	CcSEcCtD
Cyproheptadine—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.00154	0.00215	CcSEcCtD
Cyproheptadine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00154	0.00215	CcSEcCtD
Cyproheptadine—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.00153	0.00214	CcSEcCtD
Cyproheptadine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00153	0.00214	CcSEcCtD
Cyproheptadine—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.00153	0.00214	CcSEcCtD
Cyproheptadine—HRH1—vagina—acquired immunodeficiency syndrome	0.00153	0.0101	CbGeAlD
Cyproheptadine—Chills—Saquinavir—acquired immunodeficiency syndrome	0.00153	0.00213	CcSEcCtD
Cyproheptadine—Tension—Ritonavir—acquired immunodeficiency syndrome	0.00152	0.00211	CcSEcCtD
Cyproheptadine—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.00151	0.00211	CcSEcCtD
Cyproheptadine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.00151	0.00211	CcSEcCtD
Cyproheptadine—Oedema—Indinavir—acquired immunodeficiency syndrome	0.00151	0.0021	CcSEcCtD
Cyproheptadine—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.0015	0.00209	CcSEcCtD
Cyproheptadine—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.0015	0.00209	CcSEcCtD
Cyproheptadine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.0015	0.00209	CcSEcCtD
Cyproheptadine—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.0015	0.00209	CcSEcCtD
Cyproheptadine—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.00149	0.00208	CcSEcCtD
Cyproheptadine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00149	0.00207	CcSEcCtD
Cyproheptadine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00149	0.00207	CcSEcCtD
Cyproheptadine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00148	0.00207	CcSEcCtD
Cyproheptadine—Shock—Indinavir—acquired immunodeficiency syndrome	0.00148	0.00207	CcSEcCtD
Cyproheptadine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00148	0.00206	CcSEcCtD
Cyproheptadine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00148	0.00206	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.00148	0.00206	CcSEcCtD
Cyproheptadine—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.00148	0.00206	CcSEcCtD
Cyproheptadine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00147	0.00205	CcSEcCtD
Cyproheptadine—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.00147	0.00204	CcSEcCtD
Cyproheptadine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.00147	0.00204	CcSEcCtD
Cyproheptadine—Chills—Lamivudine—acquired immunodeficiency syndrome	0.00146	0.00204	CcSEcCtD
Cyproheptadine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00146	0.00203	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.00146	0.00203	CcSEcCtD
Cyproheptadine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.00146	0.00203	CcSEcCtD
Cyproheptadine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.00146	0.00203	CcSEcCtD
Cyproheptadine—HTR2A—digestive system—acquired immunodeficiency syndrome	0.00145	0.00952	CbGeAlD
Cyproheptadine—HRH1—lung—acquired immunodeficiency syndrome	0.00145	0.00952	CbGeAlD
Cyproheptadine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.00145	0.00202	CcSEcCtD
Cyproheptadine—CHRM3—brain—acquired immunodeficiency syndrome	0.00144	0.00948	CbGeAlD
Cyproheptadine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00144	0.00201	CcSEcCtD
Cyproheptadine—HTR1A—brain—acquired immunodeficiency syndrome	0.00144	0.00945	CbGeAlD
Cyproheptadine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.00144	0.002	CcSEcCtD
Cyproheptadine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.00144	0.002	CcSEcCtD
Cyproheptadine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.00143	0.00199	CcSEcCtD
Cyproheptadine—SLC6A2—brain—acquired immunodeficiency syndrome	0.00142	0.00937	CbGeAlD
Cyproheptadine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.00142	0.00198	CcSEcCtD
Cyproheptadine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.00141	0.00196	CcSEcCtD
Cyproheptadine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.0014	0.00195	CcSEcCtD
Cyproheptadine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.0014	0.00195	CcSEcCtD
Cyproheptadine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.0014	0.00195	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00139	0.00194	CcSEcCtD
Cyproheptadine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.00139	0.00194	CcSEcCtD
Cyproheptadine—Tension—Lamivudine—acquired immunodeficiency syndrome	0.00139	0.00194	CcSEcCtD
Cyproheptadine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00139	0.00194	CcSEcCtD
Cyproheptadine—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.00139	0.00193	CcSEcCtD
Cyproheptadine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00139	0.00193	CcSEcCtD
Cyproheptadine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00139	0.00193	CcSEcCtD
Cyproheptadine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.00138	0.00193	CcSEcCtD
Cyproheptadine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00138	0.00193	CcSEcCtD
Cyproheptadine—HTR2A—blood—acquired immunodeficiency syndrome	0.00138	0.00907	CbGeAlD
Cyproheptadine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.00138	0.00192	CcSEcCtD
Cyproheptadine—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.00138	0.00905	CbGeAlD
Cyproheptadine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00138	0.00192	CcSEcCtD
Cyproheptadine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.00137	0.00191	CcSEcCtD
Cyproheptadine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00137	0.0019	CcSEcCtD
Cyproheptadine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.00137	0.0019	CcSEcCtD
Cyproheptadine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00136	0.0019	CcSEcCtD
Cyproheptadine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00136	0.0019	CcSEcCtD
Cyproheptadine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00136	0.0019	CcSEcCtD
Cyproheptadine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.00136	0.00189	CcSEcCtD
Cyproheptadine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.00136	0.00189	CcSEcCtD
Cyproheptadine—Rash—Didanosine—acquired immunodeficiency syndrome	0.00135	0.00189	CcSEcCtD
Cyproheptadine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00135	0.00189	CcSEcCtD
Cyproheptadine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00135	0.00189	CcSEcCtD
Cyproheptadine—Headache—Didanosine—acquired immunodeficiency syndrome	0.00135	0.00188	CcSEcCtD
Cyproheptadine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00134	0.00187	CcSEcCtD
Cyproheptadine—HRH1—nervous system—acquired immunodeficiency syndrome	0.00134	0.00882	CbGeAlD
Cyproheptadine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00134	0.00187	CcSEcCtD
Cyproheptadine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00134	0.00187	CcSEcCtD
Cyproheptadine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00134	0.00186	CcSEcCtD
Cyproheptadine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00134	0.00186	CcSEcCtD
Cyproheptadine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00134	0.00186	CcSEcCtD
Cyproheptadine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00134	0.00186	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.00133	0.00186	CcSEcCtD
Cyproheptadine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.00133	0.00186	CcSEcCtD
Cyproheptadine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.00133	0.00185	CcSEcCtD
Cyproheptadine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00133	0.00185	CcSEcCtD
Cyproheptadine—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.00133	0.00874	CbGeAlD
Cyproheptadine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.00133	0.00185	CcSEcCtD
Cyproheptadine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00133	0.00185	CcSEcCtD
Cyproheptadine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00132	0.00184	CcSEcCtD
Cyproheptadine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00132	0.00184	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00132	0.00184	CcSEcCtD
Cyproheptadine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.00131	0.00183	CcSEcCtD
Cyproheptadine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.00131	0.00182	CcSEcCtD
Cyproheptadine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.0013	0.00181	CcSEcCtD
Cyproheptadine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.0013	0.00181	CcSEcCtD
Cyproheptadine—DRD2—brain—acquired immunodeficiency syndrome	0.0013	0.00854	CbGeAlD
Cyproheptadine—HRH1—central nervous system—acquired immunodeficiency syndrome	0.00129	0.00849	CbGeAlD
Cyproheptadine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00129	0.0018	CcSEcCtD
Cyproheptadine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00129	0.00179	CcSEcCtD
Cyproheptadine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00129	0.00179	CcSEcCtD
Cyproheptadine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00129	0.00179	CcSEcCtD
Cyproheptadine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00128	0.00178	CcSEcCtD
Cyproheptadine—HTR2A—vagina—acquired immunodeficiency syndrome	0.00128	0.00841	CbGeAlD
Cyproheptadine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00128	0.00178	CcSEcCtD
Cyproheptadine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00128	0.00178	CcSEcCtD
Cyproheptadine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00128	0.00178	CcSEcCtD
Cyproheptadine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00127	0.00177	CcSEcCtD
Cyproheptadine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00127	0.00177	CcSEcCtD
Cyproheptadine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.00127	0.00177	CcSEcCtD
Cyproheptadine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.00127	0.00177	CcSEcCtD
Cyproheptadine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00127	0.00177	CcSEcCtD
Cyproheptadine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00127	0.00176	CcSEcCtD
Cyproheptadine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00126	0.00176	CcSEcCtD
Cyproheptadine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00126	0.00175	CcSEcCtD
Cyproheptadine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00125	0.00175	CcSEcCtD
Cyproheptadine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00125	0.00174	CcSEcCtD
Cyproheptadine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00124	0.00173	CcSEcCtD
Cyproheptadine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00124	0.00173	CcSEcCtD
Cyproheptadine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.00124	0.00173	CcSEcCtD
Cyproheptadine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00124	0.00172	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.00123	0.00172	CcSEcCtD
Cyproheptadine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00123	0.00172	CcSEcCtD
Cyproheptadine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00123	0.00172	CcSEcCtD
Cyproheptadine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00123	0.00171	CcSEcCtD
Cyproheptadine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00123	0.00171	CcSEcCtD
Cyproheptadine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00123	0.00171	CcSEcCtD
Cyproheptadine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00123	0.00171	CcSEcCtD
Cyproheptadine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00122	0.00171	CcSEcCtD
Cyproheptadine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.00122	0.0017	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00122	0.0017	CcSEcCtD
Cyproheptadine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00122	0.0017	CcSEcCtD
Cyproheptadine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00122	0.0017	CcSEcCtD
Cyproheptadine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00122	0.0017	CcSEcCtD
Cyproheptadine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00121	0.00169	CcSEcCtD
Cyproheptadine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00121	0.00169	CcSEcCtD
Cyproheptadine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00121	0.00169	CcSEcCtD
Cyproheptadine—HTR2A—lung—acquired immunodeficiency syndrome	0.00121	0.00795	CbGeAlD
Cyproheptadine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00121	0.00169	CcSEcCtD
Cyproheptadine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.0012	0.00167	CcSEcCtD
Cyproheptadine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.0012	0.00167	CcSEcCtD
Cyproheptadine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.0012	0.00167	CcSEcCtD
Cyproheptadine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00119	0.00166	CcSEcCtD
Cyproheptadine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00119	0.00166	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00119	0.00165	CcSEcCtD
Cyproheptadine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00119	0.00165	CcSEcCtD
Cyproheptadine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.00118	0.00165	CcSEcCtD
Cyproheptadine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00118	0.00164	CcSEcCtD
Cyproheptadine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00118	0.00164	CcSEcCtD
Cyproheptadine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00118	0.00164	CcSEcCtD
Cyproheptadine—Rash—Stavudine—acquired immunodeficiency syndrome	0.00118	0.00164	CcSEcCtD
Cyproheptadine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00117	0.00164	CcSEcCtD
Cyproheptadine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00117	0.00164	CcSEcCtD
Cyproheptadine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00117	0.00164	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00117	0.00163	CcSEcCtD
Cyproheptadine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00117	0.00163	CcSEcCtD
Cyproheptadine—Headache—Stavudine—acquired immunodeficiency syndrome	0.00117	0.00163	CcSEcCtD
Cyproheptadine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00117	0.00163	CcSEcCtD
Cyproheptadine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.00117	0.00163	CcSEcCtD
Cyproheptadine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00117	0.00162	CcSEcCtD
Cyproheptadine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00116	0.00162	CcSEcCtD
Cyproheptadine—Rash—Abacavir—acquired immunodeficiency syndrome	0.00116	0.00161	CcSEcCtD
Cyproheptadine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00116	0.00161	CcSEcCtD
Cyproheptadine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00116	0.00161	CcSEcCtD
Cyproheptadine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.00116	0.00161	CcSEcCtD
Cyproheptadine—Headache—Abacavir—acquired immunodeficiency syndrome	0.00115	0.0016	CcSEcCtD
Cyproheptadine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00115	0.0016	CcSEcCtD
Cyproheptadine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.00114	0.00159	CcSEcCtD
Cyproheptadine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00114	0.00159	CcSEcCtD
Cyproheptadine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00113	0.00158	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.00113	0.00158	CcSEcCtD
Cyproheptadine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.00113	0.00158	CcSEcCtD
Cyproheptadine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00113	0.00158	CcSEcCtD
Cyproheptadine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00112	0.00156	CcSEcCtD
Cyproheptadine—HTR2A—nervous system—acquired immunodeficiency syndrome	0.00112	0.00737	CbGeAlD
Cyproheptadine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00112	0.00156	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00112	0.00156	CcSEcCtD
Cyproheptadine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00111	0.00155	CcSEcCtD
Cyproheptadine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00111	0.00155	CcSEcCtD
Cyproheptadine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00111	0.00155	CcSEcCtD
Cyproheptadine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00111	0.00154	CcSEcCtD
Cyproheptadine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.0011	0.00154	CcSEcCtD
Cyproheptadine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.0011	0.00153	CcSEcCtD
Cyproheptadine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.0011	0.00153	CcSEcCtD
Cyproheptadine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00109	0.00152	CcSEcCtD
Cyproheptadine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00109	0.00152	CcSEcCtD
Cyproheptadine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00109	0.00151	CcSEcCtD
Cyproheptadine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00108	0.00151	CcSEcCtD
Cyproheptadine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00108	0.00151	CcSEcCtD
Cyproheptadine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00108	0.00151	CcSEcCtD
Cyproheptadine—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.00108	0.00709	CbGeAlD
Cyproheptadine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.00108	0.0015	CcSEcCtD
Cyproheptadine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.00108	0.0015	CcSEcCtD
Cyproheptadine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00107	0.00149	CcSEcCtD
Cyproheptadine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00107	0.00149	CcSEcCtD
Cyproheptadine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.00105	0.00147	CcSEcCtD
Cyproheptadine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00105	0.00146	CcSEcCtD
Cyproheptadine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00105	0.00146	CcSEcCtD
Cyproheptadine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00104	0.00145	CcSEcCtD
Cyproheptadine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00104	0.00145	CcSEcCtD
Cyproheptadine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00104	0.00145	CcSEcCtD
Cyproheptadine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00103	0.00144	CcSEcCtD
Cyproheptadine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00103	0.00144	CcSEcCtD
Cyproheptadine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00103	0.00143	CcSEcCtD
Cyproheptadine—HRH1—brain—acquired immunodeficiency syndrome	0.00103	0.00674	CbGeAlD
Cyproheptadine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00102	0.00142	CcSEcCtD
Cyproheptadine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00102	0.00142	CcSEcCtD
Cyproheptadine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00102	0.00142	CcSEcCtD
Cyproheptadine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.00142	CcSEcCtD
Cyproheptadine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00102	0.00141	CcSEcCtD
Cyproheptadine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.00101	0.0014	CcSEcCtD
Cyproheptadine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.001	0.00139	CcSEcCtD
Cyproheptadine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000999	0.00139	CcSEcCtD
Cyproheptadine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000997	0.00139	CcSEcCtD
Cyproheptadine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000997	0.00139	CcSEcCtD
Cyproheptadine—HRH1—lymph node—acquired immunodeficiency syndrome	0.000991	0.00651	CbGeAlD
Cyproheptadine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000989	0.00138	CcSEcCtD
Cyproheptadine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000978	0.00136	CcSEcCtD
Cyproheptadine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000974	0.00136	CcSEcCtD
Cyproheptadine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000963	0.00134	CcSEcCtD
Cyproheptadine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000963	0.00134	CcSEcCtD
Cyproheptadine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000958	0.00134	CcSEcCtD
Cyproheptadine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000953	0.00133	CcSEcCtD
Cyproheptadine—Rash—Indinavir—acquired immunodeficiency syndrome	0.00095	0.00132	CcSEcCtD
Cyproheptadine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000949	0.00132	CcSEcCtD
Cyproheptadine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000944	0.00132	CcSEcCtD
Cyproheptadine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000942	0.00131	CcSEcCtD
Cyproheptadine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000932	0.0013	CcSEcCtD
Cyproheptadine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000919	0.00128	CcSEcCtD
Cyproheptadine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000905	0.00126	CcSEcCtD
Cyproheptadine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000904	0.00126	CcSEcCtD
Cyproheptadine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000901	0.00126	CcSEcCtD
Cyproheptadine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000898	0.00125	CcSEcCtD
Cyproheptadine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000897	0.00125	CcSEcCtD
Cyproheptadine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000895	0.00125	CcSEcCtD
Cyproheptadine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000892	0.00124	CcSEcCtD
Cyproheptadine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00087	0.00121	CcSEcCtD
Cyproheptadine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000866	0.00121	CcSEcCtD
Cyproheptadine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000862	0.0012	CcSEcCtD
Cyproheptadine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000859	0.0012	CcSEcCtD
Cyproheptadine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000858	0.0012	CcSEcCtD
Cyproheptadine—HTR2A—brain—acquired immunodeficiency syndrome	0.000856	0.00563	CbGeAlD
Cyproheptadine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000854	0.00119	CcSEcCtD
Cyproheptadine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000846	0.00118	CcSEcCtD
Cyproheptadine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000833	0.00116	CcSEcCtD
Cyproheptadine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00083	0.00116	CcSEcCtD
Cyproheptadine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00083	0.00116	CcSEcCtD
Cyproheptadine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000809	0.00113	CcSEcCtD
Cyproheptadine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000802	0.00112	CcSEcCtD
Cyproheptadine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000801	0.00112	CcSEcCtD
Cyproheptadine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000794	0.00111	CcSEcCtD
Cyproheptadine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000794	0.00111	CcSEcCtD
Cyproheptadine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000792	0.0011	CcSEcCtD
Cyproheptadine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000789	0.0011	CcSEcCtD
Cyproheptadine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000771	0.00107	CcSEcCtD
Cyproheptadine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000765	0.00107	CcSEcCtD
Cyproheptadine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000765	0.00107	CcSEcCtD
Cyproheptadine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000764	0.00106	CcSEcCtD
Cyproheptadine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00076	0.00106	CcSEcCtD
Cyproheptadine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000748	0.00104	CcSEcCtD
Cyproheptadine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000736	0.00103	CcSEcCtD
Cyproheptadine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000729	0.00102	CcSEcCtD
Cyproheptadine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000729	0.00102	CcSEcCtD
Cyproheptadine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000725	0.00101	CcSEcCtD
Cyproheptadine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00072	0.001	CcSEcCtD
Cyproheptadine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000687	0.000958	CcSEcCtD
Cyproheptadine—HTR2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000119	0.000912	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000119	0.00091	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000118	0.000909	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000118	0.000908	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000118	0.000908	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000118	0.000907	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000118	0.000906	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000118	0.000904	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000118	0.000903	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000117	0.0009	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000117	0.000897	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000117	0.000897	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000117	0.000895	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000116	0.000893	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000116	0.000893	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000116	0.000892	CbGpPWpGaD
Cyproheptadine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000116	0.00089	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000115	0.000886	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000115	0.000886	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000114	0.000872	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000114	0.000872	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000113	0.00087	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000113	0.00087	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000113	0.000868	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000113	0.000868	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000113	0.000867	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000113	0.000867	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000113	0.000864	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000113	0.000864	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000112	0.000856	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000112	0.000856	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000111	0.000854	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000111	0.000854	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000111	0.000852	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000111	0.000852	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000111	0.000849	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000111	0.000849	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00011	0.000847	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00011	0.000847	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00011	0.000842	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00011	0.000842	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000109	0.000838	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000109	0.000838	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000109	0.000838	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000109	0.000835	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000108	0.000831	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000108	0.000829	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000107	0.000825	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000107	0.000823	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000107	0.00082	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000107	0.000818	CbGpPWpGaD
Cyproheptadine—SLC6A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000106	0.000816	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000105	0.00081	CbGpPWpGaD
Cyproheptadine—HTR2A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.000105	0.000806	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000104	0.000801	CbGpPWpGaD
Cyproheptadine—CHRM2—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.000103	0.000791	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000103	0.000789	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000103	0.000788	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000103	0.000788	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000103	0.000787	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000102	0.000784	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000102	0.000782	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000101	0.000775	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000101	0.000775	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000101	0.000774	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000101	0.000774	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000101	0.000774	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.0001	0.000771	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.0001	0.000771	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.0001	0.000769	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.0001	0.000769	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.0001	0.000769	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.93e-05	0.000762	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	9.92e-05	0.000761	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	9.92e-05	0.000761	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.88e-05	0.000759	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	9.8e-05	0.000752	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	9.75e-05	0.000748	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	9.65e-05	0.000741	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	9.6e-05	0.000737	CbGpPWpGaD
Cyproheptadine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	9.36e-05	0.000718	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.33e-05	0.000716	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.33e-05	0.000716	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.06e-05	0.000695	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	8.9e-05	0.000683	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	8.85e-05	0.000679	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	8.83e-05	0.000677	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	8.78e-05	0.000674	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8.76e-05	0.000673	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8.72e-05	0.000669	CbGpPWpGaD
Cyproheptadine—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	8.72e-05	0.000669	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.6e-05	0.00066	CbGpPWpGaD
Cyproheptadine—CHRM1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	8.53e-05	0.000655	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.52e-05	0.000654	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.52e-05	0.000654	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.47e-05	0.00065	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.46e-05	0.00065	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.44e-05	0.000648	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.42e-05	0.000646	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.39e-05	0.000644	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.34e-05	0.00064	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.32e-05	0.000638	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.31e-05	0.000638	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.29e-05	0.000636	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.27e-05	0.000634	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.19e-05	0.000628	CbGpPWpGaD
Cyproheptadine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	8.13e-05	0.000624	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.12e-05	0.000624	CbGpPWpGaD
Cyproheptadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	8.11e-05	0.000622	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.08e-05	0.00062	CbGpPWpGaD
Cyproheptadine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	8.08e-05	0.00062	CbGpPWpGaD
Cyproheptadine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	8.06e-05	0.000618	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	8.01e-05	0.000615	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.97e-05	0.000612	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	7.81e-05	0.000599	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	7.75e-05	0.000595	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	7.69e-05	0.00059	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	7.69e-05	0.00059	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	7.67e-05	0.000589	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	7.64e-05	0.000587	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	7.62e-05	0.000585	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	7.62e-05	0.000585	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	7.61e-05	0.000584	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	7.58e-05	0.000582	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	7.57e-05	0.000581	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	7.56e-05	0.00058	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	7.55e-05	0.00058	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	7.55e-05	0.000579	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	7.53e-05	0.000578	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	7.51e-05	0.000576	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	7.49e-05	0.000575	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	7.43e-05	0.00057	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.35e-05	0.000564	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.31e-05	0.000561	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.13e-05	0.000547	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.1e-05	0.000545	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.04e-05	0.00054	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.02e-05	0.000539	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7e-05	0.000538	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.99e-05	0.000537	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	6.98e-05	0.000536	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	6.96e-05	0.000534	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	6.92e-05	0.000531	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—ALB—acquired immunodeficiency syndrome	6.92e-05	0.000531	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	6.91e-05	0.00053	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.91e-05	0.00053	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.91e-05	0.00053	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	6.89e-05	0.000529	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.89e-05	0.000529	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	6.89e-05	0.000529	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.87e-05	0.000527	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.87e-05	0.000527	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	6.86e-05	0.000527	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	6.8e-05	0.000522	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.48e-05	0.000497	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.45e-05	0.000495	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.4e-05	0.000491	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.38e-05	0.00049	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.35e-05	0.000487	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.33e-05	0.000486	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.31e-05	0.000485	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.29e-05	0.000483	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.29e-05	0.000483	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.26e-05	0.00048	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.23e-05	0.000478	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.07e-05	0.000465	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.07e-05	0.000465	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	5.97e-05	0.000458	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	5.97e-05	0.000458	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	5.95e-05	0.000457	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	5.95e-05	0.000457	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	5.94e-05	0.000456	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	5.94e-05	0.000456	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	5.92e-05	0.000454	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	5.92e-05	0.000454	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	5.86e-05	0.00045	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	5.86e-05	0.00045	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.84e-05	0.000448	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.71e-05	0.000438	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.26e-05	0.000403	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.23e-05	0.000401	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.18e-05	0.000397	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.15e-05	0.000395	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.1e-05	0.000391	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.07e-05	0.000389	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.73e-05	0.000363	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.71e-05	0.000361	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.63e-05	0.000355	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.61e-05	0.000354	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.61e-05	0.000354	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.54e-05	0.000349	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.54e-05	0.000348	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.53e-05	0.000348	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.52e-05	0.000347	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.5e-05	0.000345	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.48e-05	0.000344	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.47e-05	0.000343	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.46e-05	0.000342	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.46e-05	0.000342	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.45e-05	0.000341	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.43e-05	0.00034	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.41e-05	0.000338	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.4e-05	0.000337	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.39e-05	0.000337	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.38e-05	0.000336	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.37e-05	0.000335	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.33e-05	0.000332	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.16e-05	0.000319	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.09e-05	0.000314	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.08e-05	0.000313	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.07e-05	0.000312	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.07e-05	0.000312	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.06e-05	0.000311	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.02e-05	0.000308	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4e-05	0.000307	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.99e-05	0.000306	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.98e-05	0.000305	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.97e-05	0.000304	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.93e-05	0.000301	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.7e-05	0.000284	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.68e-05	0.000282	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—ALB—acquired immunodeficiency syndrome	3.46e-05	0.000265	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.37e-05	0.000259	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.36e-05	0.000258	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.74e-05	0.00021	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.72e-05	0.000209	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.72e-05	0.000209	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.71e-05	0.000208	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.4e-05	0.000184	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.39e-05	0.000183	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.36e-05	0.000181	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.36e-05	0.000181	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.35e-05	0.00018	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.35e-05	0.00018	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.35e-05	0.00018	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.34e-05	0.00018	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.34e-05	0.00018	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.33e-05	0.000179	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.32e-05	0.000178	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.31e-05	0.000177	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.17e-05	0.000167	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.98e-05	0.000152	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.61e-05	0.000123	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.6e-05	0.000123	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.41e-05	0.000108	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.39e-05	0.000107	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.39e-05	0.000106	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.38e-05	0.000106	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.38e-05	0.000106	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.36e-05	0.000105	CbGpPWpGaD
